---
layout: post
title: "Photocure ASA: Results for the fourth quarter of 2025"
date: 2026-02-18T06:44:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/photocure-asa-results-for-the-fourth-quarter-of-2025-302691255.html
significance: 8.00
---

<p>OSLO, Norway, Feb. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), and a commercial EBITDA of NOK 8.4 million (Q4 2024: NOK 3.9 million) for the company. In 2026,...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/photocure-asa-results-for-the-fourth-quarter-of-2025-302691255.html)

**Published:** 2026-02-18 06:44:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/photocure-asa-results-for-the-fourth-quarter-of-2025-302691255.html)
